Novavax Publicly Raising $18M To Fund Avian Flu Vaccine Work Nov. 3, 2005 By Jennifer Boggs Capitalizing on its rising stock price driven by avian flu fears, Novavax Inc. is bringing in $18 million through a public offering to support clinical development. (BioWorld Today)Read More
